X Close

Contribute

This platform seeks to provide the best possible support to improve both the health and economic outcomes from the COVID-19 pandemic. All contributions are welcome to better serve this goal. Please don't hesitate to send through relevant info using the form below. Before submitting, please make sure to check the accuracy of any information against reliable data sources, journals and other relevant publications.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Chronology of Findings

Because of the volume of publications now coming out on COVID-19 - this list makes no attempt to be exhaustive. More articles can be found by checking out some of the links on our External Resources page. If you notice something missing, click the contribute button at the bottom of this page and let us know.

Filter by Topic:

April 29, 2020

First Treatment Discovered

A Remdesivir trial showed 31% time to faster recovery when using the drug

April 13, 2020

No Pharmacologic Treatments shown effective to date

A literature review of existing pharmacologic research into COVID-19

April 6, 2020

Analysis of ICU patients in Italy

From a sample of 1591 critically ill patients in Lombardy, 99% required respiratory support. 88% intubation. Non-invasive ventilation 11%. ICU Mortality was 26% as of March 25.

March 11, 2020

Analysing mortality risk factors

Old people more vulnerable. People with comorbidities more likely to be hospitalised and result in fatalities. Average shedding of the virus for survivors was 20 days and COVID-19 was detectable until death in non-survivors. The longest observed viral shedding was 37 days. Viral shedding is associated with being infectious to others.  

February 28, 2020

WHO Report from Feb 16-24 Mission

WHO Report comes out with their initial epidemiological findings. Median age 51 years. R0 estimated at 2-2.5. Only 2.4% of cases below 18 years of age. Symptoms are said to be Fever and  Cough 87.9% and 67.7% of cases. Cases becomes symptomatic 5-6 days from infection. Approximately 80% have a mild disease, 13.8% severe and 6.1% critical. Whilst asymptomatic cases were reported the majority then went on to develop disease. True asymptomatic cases appears rare. Those above 60 years old and with comorbidities at risk. Fatality rate was 3.8% but varies by location. 5.8% in Wuhan and 0.7% in other parts of China. Mortality varied with age. 80 years 21.9%. Median time nationally from symptom onset to case confirmation came down from 12 days to 3 days by early Feb.  

February 24, 2020

Examining critically ill patients in Wuhan

Looking at those who became critically ill, average wage was 59.7, 61.5% had died at 28 days. The average time from ICU admission to death was 7 days. Those who died were older - average age 64.9 years. 81% developed ARDS and 94% required ventilation. Most patients had organ function damage.

January 24, 2020

Clinical features of early COVID-19 patients

By Jan 2nd, 41 patients had been identified with COVID-19. 73% were men. 32% had underlying diseases. Median age was 49. 66% had been exposed to Huanan Seafood Market. Fever and cough showed up in 98% and 76% of cases respectively. 100% got pneumonia. 32% were admitted to ICU and 15% died.

Examination of an early family cluster

A family of 6 were found to have contracted COVID-19 between Dec 29 - Jan 4 and demonstrated person-to-person transmission. Throat swabs were negative but RT-PCR testing showed an unknown virus confirmed to be COVID-19. They showed symptoms 3-6 days after exposure.